Polianta LTD Moderna, Inc. Transaction History

Polianta LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	BUY	$118.5 - $160.53 $1.04 Million - $1.41 Million	8,800 New	8,800 $1.07 Million
Q2 2022 Jul 19, 2022	SELL	$117.13 - $176.59 $597,363 - $900,609	-5,100 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$126.46 - $235.05 $644,946 - $1.2 Million	5,100 New	5,100 $878,000
Q4 2021 Jan 18, 2022	SELL	$225.82 - $368.51 $677,460 - $1.11 Million	-3,000 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $665,700 - $1.45 Million	3,000 New	3,000 $1.15 Million
Q2 2021 Jul 06, 2021	SELL	$129.91 - $234.98 $1.16 Million - $2.09 Million	-8,900 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$109.18 - $185.98 $971,702 - $1.66 Million	8,900 New	8,900 $1.17 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.